Loading
CV Sciences, Inc. Stock: price and insider trades · United States
1 insider bought €100k of shares over the last 90 days, the latest by CHEEVER CHARLIE E III, filed 09 Sept 2026.
Insider Decl.
78
Thresholds
n/a
Buy Volume
€2M
26 ops. · all time
Sell Volume
€1M
34 ops. · all time
Who traded when
BuySaleCharlie E. Cheever III10 buys
Since the insiders bought
- -50.0%Entry US$0.02 · Close 22 Oct 2026 US$0.01
- -86.1%Entry US$0.36 · Close at T+365 US$0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,346 of 26,290 companies
18.7
score / 100
Value8
Quality30
FCF yld-23%
Earn yld-42%
EV/EBITDA·
ROE-119%
Gross mgn49%
Net mgn-6.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.01
Analyst consensus
Income statement
RevenueUS$13.8M
Gross profitUS$6.8M49% margin
EBITDA-US$240k-2% margin
Net income-US$958k-15.7% margin
Valuation
P/Book1.4x
Beta0.43
Balance sheet & cash
Market capUS$2.3M
Total debtUS$1.6M
Free Cash Flow-US$516k
Debt / Equity80%
Profitability & ownership
ROE-118.9%
ROA-8.4%
% insiders21.4%
% institutions0.0%
Last declaration on 9 September 2026
Declarations78 total
91,387 shares@ US$0.020.080% mcap1.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:0
Canonical exit: 14 Oct 2026 (T+90)
749,000 shares@ US$0.020.66% mcap13.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:1
Canonical exit: 15 Oct 2026 (T+90)
335,000 shares@ US$0.020.30% mcap5.8% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:2
Canonical exit: 19 Oct 2026 (T+90)
272,500 shares@ US$0.020.24% mcap4.8% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:3
Canonical exit: 20 Oct 2026 (T+90)
470,075 shares@ US$0.020.41% mcap8.2% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:4
Canonical exit: 22 Oct 2026 (T+90)
1,830,000 shares@ US$0.021.60% mcap32.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:5
Canonical exit: 26 Oct 2026 (T+90)
60,000 shares@ US$0.020.052% mcap1.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:6
Canonical exit: 27 Oct 2026 (T+90)
1,730,000 shares@ US$0.021.49% mcap29.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:7
Canonical exit: 29 Oct 2026 (T+90)
108,000 shares@ US$0.020.093% mcap1.9% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:8
Canonical exit: 2 Nov 2026 (T+90)
94,854 shares@ US$0.020.082% mcap1.6% of flowCommon Stock, $0.0001 par value per shareSEC:0001202557-26-000005:9
Canonical exit: 5 Nov 2026 (T+90)
50,000 shares@ US$0.38100.0% of flowCommon StockSEC:0001510964-21-000030:0
Canonical exit: 19 Aug 2021 (T+90)
100,000 shares@ US$0.6107Common StockSEC:0001572795-21-000002:0
100,000 shares@ US$0.6295Common StockSEC:0001572795-21-000002:1
16,600 shares@ US$0.659Common StockSEC:0001572795-21-000002:2
75,000 shares@ US$0.555Common StockSEC:0001572795-21-000001:0
75,140 shares@ US$0.5707Common StockSEC:0001572795-21-000001:1
400,000 shares@ US$0.5863Common StockSEC:0001572795-20-000005:0
57,400 shares@ US$0.6138Common StockSEC:0001572795-20-000005:1
42,800 shares@ US$0.6121Common StockSEC:0001572795-20-000005:2
50,000 shares@ US$0.5834Common StockSEC:0001572795-20-000004:0
58,535 shares@ US$0.5801Common StockSEC:0001572795-20-000004:1
30,000 shares@ US$0.80Common StockSEC:0001572795-20-000003:0
8,803 shares@ US$0.80Common StockSEC:0001572795-20-000003:1
12,801 shares@ US$0.39Common StockSEC:0001510964-20-000043:0
Canonical exit: 12 Aug 2020 (T+90)
6,379 shares@ US$1.00Common StockSEC:0001572795-20-000002:0
25 of 78 declarations
About CV Sciences, Inc.
At CV Sciences, Inc., Michael Joseph Mona Jr., a 10% owner, signs 34 sales across 36 filings, none with an amount, while the purchases do carry amounts: 21 purchases (11 with an amount) for EUR 115,909, median EUR 5,869. Charlie E. Cheever III, also a 10% owner, bought EUR 32,168 on July 28, 2026 and EUR 30,040 on July 31, 2026, among 10 purchases across 10 filings. Joseph C. Maroon MD, a director, bought EUR 15,541 on May 21, 2021 and has 4 purchases across 4 filings, as does Larry Phillip Raskin, a director.
Ten insiders filed 66 times between January 19, 2016 and September 9, 2026, with a peak of 31 in 2020. Bart P. Mackay, a director, signs 6, with no purchase or sale. From November 7 to December 5, 2019, 3 insiders filed clustered trades.
Read moreShow less
Filings are published a median of 13 days after the trade. Market capitalisation is USD 2,258,291, and insiders hold 21.4%. The 10 filings of the last twelve months are all purchases. Purchases make up 38% of open-market trades.
